Letter from the Trustees – 2022

Letter from the Trustees – 2022

Seasons Greetings London – Dec 2022   Letter from the Trustees Dear Donors & Partners, Another eventful year for the foundation and we thank our donors, partners and well-wishers for the continued support. Amoke Ward @ UCH, Ibadan, our main pain...
Repurposing Mitapivat

Repurposing Mitapivat

    Researchers study a new way to treat sickle cell disease. NIH June 2022 Activating a protein in red blood cells may improve anaemia and alleviate acute episodes of severe pain for people living with sickle cell disease    Swee Lay Thein, M.B., D.Sc., a senior...
Amoke PMH Acquires TCD Machine

Amoke PMH Acquires TCD Machine

TCD Ultrasonography Equipment London – Mar 2022 Amoke Foundation acquired a Transcranial Doppler (TCD) Ultrasound Machine for use in the Southwest region of Nigeria. The equipment has been shipped to our pain management hub (PMH) that is strategically located to...
Gene Therapy

Gene Therapy

Fixing the sickle cell disease gene London – Jan 2022 Sickle cell disease (SCD) is a genetic disorder caused by a mutation in both copies of a person’s HBB gene. This gene encodes a component of haemoglobin, the oxygen-carrying protein in red blood cells. The...
Letter from the Trustees

Letter from the Trustees

Progress Against Our Social Business Strategy Ibadan – Dec 2021   Letter from the Trustees Dear Donors & Partners, As the calendar year draws to a close and the festive period gets underway, we hope you will have the opportunity to connect and spend...
Donate